Skip to main content

Table 3 Effect of tamsulosin only on group A

From: The impact of adding solifenacin to tamsulosin therapy for treatment of storage lower urinary tract symptoms owing to benign prostatic hyperplasia

P-value

After (mean ± SD)

Before (mean ± SD)

 

< 0.001

2.30 ± 0.50

4.36 ± 0.52

(1) Quality of life

< 0.001*

7.87 ± 1.555

11.63 ± 1.475

(2) OABSS

  1. Asterisk represents significant difference between both groups: P value < 0.05 was considered statistically significant